HTLS 2020: Dr Ashish Jha asks people not to worry approximately long-term immunity from Covid-19 – htls

0
18

Dr Ashish K Jha, Dean, Brown University School of Public Health on Thursday said that data and research done on immunity from Covid-19 has been reassuring and said that expecting a lifelong 100% immunity from the coronavirus is unrealistic, in conversation with Hindustan Times editor-in-chief Sukumar Ranganathan all over the inaugural session of the 18th Hindustan Times Leadership Summit.

Jha said, “Immunity is complicated. We realize that across the world 50-60 million people have been infected with the virus. There have been reinfections two months after the initial infection but those are very unusual.”

WATCH | ‘2 phases of Covid…’: How our coronavirus understanding evolved #HTLS2020

He also said that lifelong immunity from any virus isn’t a realistic expectation. He said people can expect to be immune for no less than ‘a year or longer.’ Jha said that the findings show that people who have retrieved from Covid-19 have gained immunity for eight or nine months, barring a couple of exceptions.

Jha pointed out that the medical and scientific community should not have immense amounts of experience in dealing with SARS-Cov-2 as it is reasonably new. He said that people must also not worry themselves with studies concerning antibodies.

He highlighted that immunity will be closely studied as Covid-19 vaccines are rolled out. He said, “Immunity (gained) looks love it remains durable for 8-9 months. At this point, I will be betting that most of the people may remain immune for no less than one year… Based on all of that my guess at this time is but we need to get a booster shot once a year, that’s okay, it’s not great. It will last more, we have no idea.”

Also Read| HTLS 2020: Is India able for another pandemic? AIIMS director Dr Guleria answers

Jha advised people not to look into the headlines and said that he himself does not worry approximately immunity.

The 18th Hindustan Times Leadership Summit’s inaugural session used to be also attended by All India Institute of Medical Sciences director Dr Randeep Guleria and chief executive officer of the Serum Institute of India Adar Poonawalla who discussed Covid-19, the vaccine race and the future of healthcare in India.

Top stories/ News / India

LEAVE A REPLY

Please enter your comment!
Please enter your name here